- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Anne Schmidt Says Telemedicine Utilization Lower Than Expected
Contrary to concerns that telemedicine could be overused, some programs are seeing lower involvement than expected, according to Anne Schmidt, MD, associate medical director at Blue Cross and Blue Shield of Alabama.
Contrary to concerns that telemedicine could be overused, some programs are seeing lower involvement than expected, according to Anne Schmidt, MD, associate medical director at Blue Cross and Blue Shield of Alabama.
Transcript (slightly modified)
Overutilization is one of the concerns with telemedicine. What are some of the challenges with controlling utilization of telemedicine?
For utilization of telemedicine, I think what we’re seeing is there’s actually less utilization than we’d expected. We have a teledoc program which we consider telehealth, versus a true telemedicine program, which we would define as a synchronous one-on-one interaction with a physician, a scheduled interaction, so say a consultation with a dermatologist or an infectious disease consultant. So we try to keep that distinct from telehealth, which I think is what we’re talking about with diabetes.
The utilization hasn’t been as high as we’d even expected with the specialty telemedicine programs, and we’re really trying to promote that. As far as overutilization, I think we might be looking at the wrong side. I think we need to engage more folks in their own healthcare and get them involved, and so I really don’t think we’ve seen overutilization of any programs that have so far been implemented.
As far as with reimbursement, again, we’ll have to look at data to see what the outcomes are for the general wellness programs, but I think the more involved that we can get patients in their own healthcare, and if telehealth is the way to do that, then I think everybody would benefit.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
